Results

Total Results: 1,169 records

Showing results for "patient safety".

221. Comparative Effectiveness Review No. 258_Diagnostic Errors in the Emergency Department: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diagnostic-error-executive-summary.pdf
     August 01, 2023 - The causal and risk factor literature was strongest for patient and illness characteristics and relatively … safety concern. … Diagnostic error in the emergency department: learning from national patient safety incident report … Improving Diagnostic Quality and Safety Final Report. 2017. … BMJ quality & safety. 2018 Jul;27(7):567- 70. doi: 10.1136/bmjqs-2018-007945.

222. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0122_06-29-2009.pdf
     January 01, 2009 - Description Nominator: Individual Nomination Summary: The nominator is interested in the safety …  This topic will move forward as a new systematic review that will address the safety, effectiveness … It may also address issues around patient monitoring, nursing protocol, collaborative care, and potential

223. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Experts wanted to see additional clinical trial data assessing baclofen’s long-term safety and efficacy … solution to a reference product; a user experience study with adult and juvenile volunteers; and a safety … All adult volunteers, and 15 of 19 adolescent volunteers, successfully used Evzio, removing the safety … to patients’ families that it be available for emergency use at home. … , and patients’ families, the experts concluded.

224. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Experts cited the cost, need for daily injections, and unknown long-term safety profile as potential … Patients were reported to have generally tolerated the balloon well, with one early removal for patient … .”38 However, two experts anticipated lower patient acceptance.37,42 One clinical expert stated, “Patients … Perioperative safety in the longitudinal assessment of bariatric surgery. … Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-81.

225. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
     January 01, 2007 - Results of Topic Selection Process & Next Steps  Recombinant human growth hormone in patients … What is the evidence for harms of rhGH in CF patients? … )  Cystic Fibrosis affects both children and adults, and its clinical course varies from patient … to patient. … how-are-research-topics-chosen/ Topic Number(s): 0003 Document Completion Date: 6-2-09 2  The safety

226. An analytical framework for quantifying components of variability in prescriber decisions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
     April 01, 2010 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and … Instrumental variable methods in comparative safety and effectiveness research. … Similarly, one could assess safety in these same patients by exploring the association between formulary … In some cases, the concept of a “marginal patient” may be problematic as individual patients may be … Distance must also not be related to patient characteristics.

227. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
     October 01, 2010 - Results pg 23 - patient level characteristics. … In Key question 2 - patient level factors - age has very important implications. … - The primary safety cohort for the study included 139 patients. … - Overall, the primary and secondary safety analyses performed to date represent an excellent safety … In Key question 2 - patient level factors - age has very important implications.

228. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - abuse by increasing the perceived safety of a harmful behavior. … Commercial clients pay annual licensing fees for CaringTXT, prorated on projected patient populations … CaringTXT annual licenses cost about $12,000 to $18,000 for an average-sized university or college client … Across all client types, patients pay for text messages only if the service is not included in their … As of June 2015, CaringTXT was in use by clients including the University of Pittsburgh and the Central

229. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - ability  to  improve  patient-­‐reported  symptoms,  functional  capacity,  or  quality … (Low) KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence, … Conclusion probably out of date regarding safety for TB patients. … ability to improve patient-reported symptoms, functional capacity, or quality of life? … (Low) KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence,

230. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - ability  to  improve  patient-­‐reported  symptoms,  functional  capacity,  or  quality … (Low) KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence, … Conclusion probably out of date regarding safety for TB patients. … ability to improve patient-reported symptoms, functional capacity, or quality of life? … (Low) KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence,

231. App-F-Surv-Report-3-Acute-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f-surv-report-3-acute-pain.xlsx
     May 29, 2025 - Patient Masked? Reporting of Attrition, Crossovers, Adherence, and Contamination? … Yes No No No Yes No/No Yes Yes Yes Fair Cooper, 2021 Yes Yes Yes Unclear Yes Yes Yes No/No Yes; for safety … Yes Poor Ilyas, 2021 No (by birth year) No Yes Yes No No Yes No/No No Yes; excluded 44 randomized patients … No No Unclear/Yes No Yes; 17% Yes Poor Rian, 2021 Yes Unclear Yes Yes Yes Yes Yes No/No No Yes; 13 patients

232. App-F-Surv-Report-2-Acute-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f-surv-report-2-acute-pain.xlsx
     May 29, 2025 - Patient Masked? Reporting of Attrition, Crossovers, Adherence, and Contamination? … Yes No No No Yes No/No Yes Yes Yes Fair Cooper, 2021 Yes Yes Yes Unclear Yes Yes Yes No/No Yes; for safety … Yes Poor Ilyas, 2021 No (by birth year) No Yes Yes No No Yes No/No No Yes; excluded 44 randomized patients … No No Unclear/Yes No Yes; 17% Yes Poor Rian, 2021 Yes Unclear Yes Yes Yes Yes Yes No/No No Yes; 13 patients

233. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
     August 05, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness and Safety … In addition, efficacy and safety may vary for individual drugs within a class. … We will also include studies that report safety in patients with rheumatoid arthritis or were taking … ; setting (primary care or referral); the number of patients randomized relative to the number of patients … Comparative effectiveness and safety of analgesics for osteoarthritis.

234. Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review. Evidence Summary. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
     November 01, 2017 - • To assess the comparative safety and effectiveness of pharmacologic and nonpharmacologic treatments … KQ 2: What are the comparative safety and effectiveness of pharmacologic and nonpharmacologic depression … instruments:a Beck Depression Inventory-II (BDI-II); Hospital Anxiety and Depression Scale (HADS); Patient … • One or two specific items from validated screening scales (BDI-II, Patient Health Questionnaire … 4 studies that examined the comparative safety and effectiveness of pharmacologic and nonpharmacologic

235. Registry of Patient Registries (RoPR) Policies and Procedures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-2_1.pdf
     January 01, 2012 - The DEcIDE network assists health care providers, patients, and policymakers seeking unbiased information … about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … Stakeholders included representatives from eight major groups: patients/consumers; physicians, hospitals … information within a distinct patient registry study type. … Stakeholders included representatives from eight major groups: patients/consumers; physicians, hospitals

236. Making Sure That Evidence Is Understood and Used (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-making-sure-evidence-understood.pdf
     July 01, 2020 - Department of Health and Human Services that is charged with improving the quality, safety, efficiency … What information is needed to make better recommendations to patients? … Consumers, patients, caregivers, and patient advocacy organizations It is vital that research answer … with accurate, independent, scientifically rigorous information for comparing the effectiveness and safety … Patient, Population or Problem: ◆ The “P” in PICO(TS) is a description of the patient(s) of interest

237. Angina-Heart-Attack-Treatments Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
     January 01, 2014 - effectiveness and safety differ? … and safety differ? … and safety differ? … and anticoagulant therapies in UA/NSTEMI patients, we had to broaden our eligible patient population … acute coronary syndrome: a meta-analysis of individual patient data.

238. Asthma-Immunotherapy-2010 Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
     January 01, 2010 - KQ2: What is the evidence for safety of SIT in patients with allergic rhinoconjunctivitis and/or asthma … What is the evidence for safety of subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis … What is the evidence for safety of sublingual immunotherapy in patients with allergic rhinoconjunctivitis … What is the evidence for safety of subcutaneous versus sublingual immunotherapy in patients with … help inform patients on the efficacy and safety of allergen immunotherapy.

239. Nephropathy-Contrast-Induced Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
     January 01, 2016 - How do benefits or harms of contrast media differ by patient characteristics (known risk factors such … definitive evidence of a difference in CIN incidence between IOCM and LOCM that varied according to patient … A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of … The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta- analysis of … Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized

240. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - differ in safety, adverse events, tolerability, persistence, and adherence? … Specific patient subgroups evaluated will be stratified by sex, comorbidities, concurrent medication … major cardiovascular events [myocardial infarction , stroke] and measures of quality of life) o Safety … diabetes) Adverse Events •Weight gain •Impaired renal function •Angioedema •Cough •Hyperkalemia Safety … The safety outcomes will be framed to help identify angioedema and hyperkalemia, which are both adverse